THEMONT-AX Tablets contain a combination of Levocetirizine Dihydrochloride 5 mg, Montelukast Sodium 10 mg and Ambroxol Hydrochloride 75 mg (Sustained Release). The bilayered film-coated tablet formulation is supplied in 10×10 Alu-Alu packing and is intended for use as directed by a qualified healthcare professional.
Key Highlights
- Levocetirizine Dihydrochloride 5 mg
- Montelukast Sodium 10 mg
- Ambroxol Hydrochloride 75 mg (Sustained Release)
- Bilayered film-coated tablet formulation
- 10 × 10 Alu-Alu packing
- Prescription pharmaceutical formulation
- Use as directed by a qualified healthcare professional






